Clinical Trial Update: Novel Index (PIMR) in PAH

View source ↗

Summary

A completed clinical study evaluating the Novel Index (PIMR) in pulmonary arterial hypertension, sponsored by the University of California, Los Angeles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of California, Los Angeles | Conditions: Pulmonary Hypertension | Status: COMPLETED